According to the National Aids Education & Services for Minorities, Inc., or NAESM, 44% of new HIV infections are among Black ...
Pharmaceutical company Gilead Sciences has refused to directly sell its HIV prevention drug to Doctors Without Borders.
1h
Hardest hit being left behind as Kenya rolls out ‘breakthrough’ HIV prevention jab, charity says
Jeffrey Okoro, of CFK Africa, tells Rachel Hagan that the drug lenacapavir can be transformative, but Kenya’s rollout is not ...
By Ben Ezeamalu and Jennifer Rigby MAKURDI, Nigeria, March 31 (Reuters) - For several months last year, Josephine Angev ...
For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs ...
Preview this article 1 min A humanitarian group says the company’s supply efforts aren’t meeting the moment. How AI is ...
The Access Framework outlines how, by 2030, countries can ensure that 90% of people in need of prevention services have access and that 90% of people living with HIV are virally suppressed. This, in ...
The number of Latinos with HIV or AIDS in Chicago grew nearly 17% between 2020 to 2024 while other racial groups saw a drop, ...
GlobalData on MSN
Roche unveils cobas MPX-E assay for HIV and hepatitis viruses
The assay is developed to address current demands of laboratories.
WPEC CBS 12 on MSN
Florida approves ADAP bridge funding to keep HIV meds covered through June 30, 2026
Temporary bridge funding was approved for those living with HIV and AIDS.A Wednesday news release from Beach County says the ...
Research on best options is sparse, but biologics can still be helpful for HIV-positive patients with psoriasis.
A study was conducted to determine the association between TG/HDL-C ratio and risk for CVD in patients with HIV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results